DermBiont, Inc.
DermBiont, Inc. pioneering the world’s leading precision dermatology company developing targeted topical therapeutics that address the root cause of skin diseases. Mining our curated library of microbes to build a pipeline of products to treat identified dysbiosis across indications. Bacteria, fungi and other microorganisms reside in the upper, or superficial, layers of skin, as well as on hair follicles. They survive on dead skin and oily secretions shed by healthy tissue. Skin has evolved to support a diversity of microbes, which outcompete pathogens, preventing them from entering the body and causing disease. DermBiont serves customers in the United States.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Clinical Services
- Market Focus:
- Nationally (across the country)
About us
-
Developing targeted topical therapeutics that impact the root cause of diseases, beginning with:
-
Biotherapeutics repairing a dysbiosis of the microbiome
-
Targeted small molecule therapeutics with well-defined mechanisms of action
-
-
Leveraging computational biology and our proprietary bioinformatics platform to identify clinically meaningful dysbiosis related to common skin diseases